Canary Speech Secures 13M for AI
Canary Speech , Inc. ( Canary ), a pioneer in AI-powered voice biomarker technology, raises a $ 13M Series A funding round.
Canary Speech , Inc. ( Canary ), a pioneer in AI-powered voice biomarker technology, announced today it has closed a $ 13M Series A funding round. - The round was led by Cortes Capital, LLC (Love's Private Equity), with participation from Sorenson Communications, LLC., SMK (Japan), and Hackensack Meridian Health. Canary's Cutting-Edge...
Canary Speech Secures Funding For AI
Canary Speech secures $ 13M in Series A funding to advance their AI -enabled speech recognition software, revolutionizing healthcare diagnostics with vocal biomarkers .
About Canary Speech Canary Speech is the leading AI-powered voice biomarker health tech company that uses real-time patented vocal analysis to screen for mental health and neurological disorders.
Canary Speech secures 13M for AI
Canary Speech , maker of AI -enabled speech evaluation software, introduced it scored $13 million in Series A funding. Cortes Capital, LLC (Love's Private Equity) led the spherical with participation from SMK (Japan), Hackensack Meridian Health and Sorenson Communications, LLC. WHAT IT DOES Canary provides vocal biomarker know-how that captures and analyzes information to find out whether or ...
Canary Speech secured a US$13M Series A investment, advancing AI-powered voice biomarker technology in the healthcare industry.
Canary Speech secures 13M for AI
Canary Speech , maker of AI -enabled speech analysis software, announced it scored $13 million in Series A funding. Cortes Capital (Love's Private Equity) led the round, with participation from SMK (Japan), Hackensack Meridian Health and Sorenson Communications. Canary offers vocal biomarker ...
Canary Speech , Inc., the leading AI-powered voice biomarker health tech company, has secured a $13 million Series A funding round.
Canary Speech Secures 13 Million in Series A Funding to Change How the ...
Canary Speech , an AI-powered voice biomarker health tech company, has secured a $13 million Series A funding round led by Cortes Capital, LLC (Love's Private Equity), with participation from Sorenson Communications, LLC., SMK (Japan), and Hackensack Meridian Health.
Canary Speech's patented voice biomarker technology harnesses the power of voice AI to screen for mood and disease states with just 20 seconds of speech .